FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890904631> ?p ?o ?g. }

• W2890904631 abstract "Human immune globulin (Ig) products are currently recommended as post-exposure prophylaxis (PEP) for measles in certain susceptible groups. However, successful measles vaccination programs in North America have led to low circulation of measles virus and most blood donors now have vaccine-derived immunity. Concurrently, the concentrations of anti-measles antibodies in human Ig products have shown trends of gradual decline and previously recommended doses and routes of administration may no longer be optimally protective.To review the literature and update recommendations on post-exposure prophylaxis for measles, including dosing and route of administration, for measles Ig PEP in susceptible infants and in individuals who are immunocompromised or pregnant, in order to prevent severe disease.The National Advisory Committee on Immunization (NACI) Measles, Mumps, Rubella, Varicella Working Group reviewed key literature, international practices, and product information for current Ig products pertaining to the optimal dosage and routes of Ig administration for measles PEP. It then proposed evidence-based changes to the PEP recommendations that were considered and approved by NACI.NACI continues to recommend that susceptible immunocompetent individuals six months of age and older, who are exposed to measles and who have no contraindications be given measles-mumps-rubella (MMR) vaccine within 72 hours of the exposure. NACI recommends that for susceptible infants younger than six months of age, if injection volume is not a major concern, intramuscular immunoglobulin (IMIg) should be provided at a concentration of 0.5 mL/kg, to a maximum dose of 15 mL administered over multiple injection sites. Susceptible infants six to 12 months old who are identified after 72 hours and within six days of measles exposure should receive IMIg (0.5 mL/kg) if injection volume is not a major concern. For susceptible contacts who are pregnant or immunocompromised, if injection volume is not a concern, IMIg can be provided at a concentration of 0.5 mL/kg understanding that recipients 30 kg or more will not receive the measles antibody concentrations that are considered to be fully protective. Alternatively, in cases where injection volume is a major concern or for recipients 30 kg or more, intravenous immunoglobulin (IVIg) can be provided at a dose of 400 mg/kg.NACI does not recommend that susceptible immunocompetent individuals older than 12 months of age receive Ig PEP for measles exposure due to the low risk of disease complications and the practical challenges of administration for case and contact management.NACI has updated the recommendations for measles PEP to reflect current evidence and best practices in order to prevent severe disease in Canada. Consistent with recommendations in other countries, this includes consideration of off-label use of IVIg in some instances." @default.
• W2890904631 created "2018-09-27" @default.
• W2890904631 creator A5000025409 @default.
• W2890904631 creator A5022761662 @default.
• W2890904631 creator A5039590618 @default.
• W2890904631 creator A5061178305 @default.
• W2890904631 date "2018-09-06" @default.
• W2890904631 modified "2023-10-16" @default.
• W2890904631 title "Updated NACI recommendation for measles post-exposure prophylaxis" @default.
• W2890904631 cites W1271672204 @default.
• W2890904631 cites W2006161766 @default.
• W2890904631 cites W2033142985 @default.
• W2890904631 cites W2103765124 @default.
• W2890904631 cites W2169827555 @default.
• W2890904631 cites W2605150732 @default.
• W2890904631 cites W4212971034 @default.
• W2890904631 doi "https://doi.org/10.14745/ccdr.v44i09a07" @default.
• W2890904631 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6449113" @default.
• W2890904631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31015814" @default.
• W2890904631 hasPublicationYear "2018" @default.
• W2890904631 type Work @default.
• W2890904631 sameAs 2890904631 @default.
• W2890904631 citedByCount "7" @default.
• W2890904631 countsByYear W28909046312018 @default.
• W2890904631 countsByYear W28909046312019 @default.
• W2890904631 countsByYear W28909046312020 @default.
• W2890904631 countsByYear W28909046312021 @default.
• W2890904631 crossrefType "journal-article" @default.
• W2890904631 hasAuthorship W2890904631A5000025409 @default.
• W2890904631 hasAuthorship W2890904631A5022761662 @default.
• W2890904631 hasAuthorship W2890904631A5039590618 @default.
• W2890904631 hasAuthorship W2890904631A5061178305 @default.
• W2890904631 hasBestOaLocation W28909046311 @default.
• W2890904631 hasConcept C126322002 @default.
• W2890904631 hasConcept C159654299 @default.
• W2890904631 hasConcept C187212893 @default.
• W2890904631 hasConcept C203014093 @default.
• W2890904631 hasConcept C22070199 @default.
• W2890904631 hasConcept C2776438120 @default.
• W2890904631 hasConcept C2777288759 @default.
• W2890904631 hasConcept C2778199166 @default.
• W2890904631 hasConcept C2778814567 @default.
• W2890904631 hasConcept C2779341262 @default.
• W2890904631 hasConcept C2780801004 @default.
• W2890904631 hasConcept C71924100 @default.
• W2890904631 hasConcept C8891405 @default.
• W2890904631 hasConceptScore W2890904631C126322002 @default.
• W2890904631 hasConceptScore W2890904631C159654299 @default.
• W2890904631 hasConceptScore W2890904631C187212893 @default.
• W2890904631 hasConceptScore W2890904631C203014093 @default.
• W2890904631 hasConceptScore W2890904631C22070199 @default.
• W2890904631 hasConceptScore W2890904631C2776438120 @default.
• W2890904631 hasConceptScore W2890904631C2777288759 @default.
• W2890904631 hasConceptScore W2890904631C2778199166 @default.
• W2890904631 hasConceptScore W2890904631C2778814567 @default.
• W2890904631 hasConceptScore W2890904631C2779341262 @default.
• W2890904631 hasConceptScore W2890904631C2780801004 @default.
• W2890904631 hasConceptScore W2890904631C71924100 @default.
• W2890904631 hasConceptScore W2890904631C8891405 @default.
• W2890904631 hasLocation W28909046311 @default.
• W2890904631 hasLocation W28909046312 @default.
• W2890904631 hasLocation W28909046313 @default.
• W2890904631 hasLocation W28909046314 @default.
• W2890904631 hasOpenAccess W2890904631 @default.
• W2890904631 hasPrimaryLocation W28909046311 @default.
• W2890904631 hasRelatedWork W1616836505 @default.
• W2890904631 hasRelatedWork W1885703994 @default.
• W2890904631 hasRelatedWork W2020608873 @default.
• W2890904631 hasRelatedWork W2043148249 @default.
• W2890904631 hasRelatedWork W2062692562 @default.
• W2890904631 hasRelatedWork W2163343141 @default.
• W2890904631 hasRelatedWork W2170033989 @default.
• W2890904631 hasRelatedWork W2423249175 @default.
• W2890904631 hasRelatedWork W2474978560 @default.
• W2890904631 hasRelatedWork W3160208356 @default.
• W2890904631 isParatext "false" @default.
• W2890904631 isRetracted "false" @default.
• W2890904631 magId "2890904631" @default.
• W2890904631 workType "article" @default.